Analysis
Cash flow, production ramp-up in focus as Tesla (TSLA) gets ready for Q1 report
For Tesla Inc. (NASDAQ: TSLA), 2020 will be a crucial year in terms of staying profitable and meeting...
ADVERTISEMENT
Analysis
Expert equity analysis, earnings previews, and data-driven market research.
Latest Research
2,318 articles
Analysis
Facebook (FB) to benefit from traffic surge in Q1; advertising slump damps long-term outlook
The tech industry was less affected by the pandemic-induced disruption than most other businesses, thanks to the surge...
Analysis
Unshaken by Covid, Alphabet to gain from high internet traffic in Q1
Alphabet Inc. (GOOG, GOOGL), the parent of internet search giant Google, is one of the few Wall Street...
Analysis
Chipotle Mexican Grill’s investments in digital platform, loyalty program pay off
Chipotle Mexican Grill (NYSE: CMG), said the investments it made in the digital platforms and loyalty programs are...
Analysis
Xilinx Q4 Earnings Call Highlights: Samsung deal allays near-term growth concerns
Xilinx, Inc. (NASDAQ: XLNX) got a fresh boost after clinching a major partnership with Samsung recently to supply...
Analysis
Delay in filing Biogen’s Alzheimer’s drug leaves analysts scratching head during conference call
Late last year, Biogen (NASDAQ: BIIB) made an announcement that left investors gung-ho. The stock soared 27% after...
Analysis
Why LendingTree (TREE) can be a good investment in times of crisis
All businesses have been affected by the coronavirus outbreak that sent stock markets into a tailspin recently, and...
Analysis
L Brands (LB) stock tanks as Sycamore wants to reverse its decision of buying Victoria’s Secret
In a day when the US stock market closed in the positive territory after registering negative returns in...
Analysis
Netflix content chief Ted Sarandos provides latest production updates
Netflix (NASDAQ: NFLX) did not deliver an exceptional quarter like many were hoping for when it reported first-quarter...
Analysis
Johnson & Johnson mentioned COVID 80 times during earnings call, vs. Abbott’s 16
Global pharma giants Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) announced their earnings for Q1...
Analysis
Intel (INTC) Q1 Earnings Preview: Chipmaker appears mostly unaffected by COVID-19
The impact of the coronavirus outbreak on the highly cyclical semiconductor industry is yet to be fully assessed...
Analysis
JB Hunt (JBHT) analysis: The bumpy ride won’t kill
The COVID-19 outbreak has thrown economies into a recession, and the logistics industry is one that does not...